| 摘要: |
| 目的 通过溶出曲线的检测,探索马来酸依那普利片的溶出行为,降低生物等效性试验的风险。方法 检测马来酸依那普利片不同处方的溶出曲线,确定溶出曲线与参比制剂最相似的处方。结果 自制片的3个处方中,外加预胶化淀粉为8.64 mg的处方比参比制剂溶出慢,外加预胶化淀粉为28.64 mg的处方比参比制剂快,外加预胶化淀粉为18.64 mg的处方与参比制剂拟合较好。结论 通过对马来酸依那普利片不同处方的溶出曲线检测,并与参比制剂进行对比,筛选出能与参比制剂拟合较好的处方,有效的马来酸依那普利片降低了生物等效性试验的风险。 |
| 关键词: 马来酸依那普利片 溶出曲线 生物等效 |
| DOI:10.13506/j.cnki.jpr.2018.02.009 |
| 基金项目: |
|
|
|
| In vitro dissolution curves of Enalapril Maleate Tablets |
| RAN Maoxiang,LIU Yannan |
| (Cisen Pharmaceutical Co.,Ltd.,Jining 272000,China) |
| Abstract: |
| Objective To explore the dissolution behavior of Enalapril Maleate Tablets through the detection of dissolution curve,and reduce the risk of bioequivalence test.Methods The dissolution profile of different Enalapril Maleate Tablets was determined to definite the prescription with the most similar dissolution profile to the reference formulation.Results In the three prescriptions,the prescription with plus pregelatinized starch 8.64 mg was slower than the reference formulation, the prescription with plus pregelatinized starch 28.64 mg was faster than the reference formulation.The formulation with plus pregelatinized starch 18.64 mg was better fitted to the reference formulation.Conclusion Through the dissolution curve of different prescriptions of Enalapril Maleate Tablets,compared with the reference formulation, the prescription that can be fit well to the reference formulation was screened,which effectively reduced enalapril maleate risk of bioequivalence testing. |
| Key words: Enalapril Maleate Tablets Dissolution curve Bioequivalence |